Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0000899243-23-018211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-17 | 2023-08-15 | AMLX | Morningside Venture Investments Ltd | 10% | G - Gift | $0.00 | -2.00M | 5.00M | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | G | D | 2,000,000 | $0.00 | 4,997,302 | D | — | — | (F1) Reflects the gift / charitable donation of common stock to a 501(c)(3) non-profit organization. This is not a market transaction, thus no price has been reported. No value was received by the seller for the gifted shares. (F2) Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL and disclaim any personal beneficial ownership of any shares held by MVIL. |